On September 28, all four major crypto spot ETFs—Bitcoin, Ethereum, Solana, and XRP—recorded net inflows totaling about $65 million, highlighting growing institutional demand beyond Bitcoin alone. Bitcoin ETFs led with $31.07 million, followed by Ethereum at $17.10 million, Solana at $12.70 million, and XRP at $3.96 million. Since their launches, Bitcoin spot ETFs have accumulated $57.58 billion in net inflows, Ethereum $13.96 billion, XRP $1.79 billion, and Solana $1.62 billion. Solana ETFs attract interest partly due to staking yield features, while XRP ETFs benefit from regulatory clarity after the SEC lawsuit resolution, fueling pent-up investor demand.
The recent net inflows into Bitcoin, Ethereum, Solana, and XRP spot ETFs provide context for crypto market activity. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Sep 29, 2026 13:41 WIB: among 50 major cryptocurrencies priced on Pluang, 23 rose and 26 fell. Notable movers include EOS with a 1-day change of +8.13% at Rp12.649 and LINK with +8.12% at Rp268.759, while GRT declined by -6.69% to Rp543.
The cryptocurrency AAVE surged 9.31% within four hours to reach $163, extending its 24-hour gain to 10.07%. This price increase was accompanied by $140,000 in short liquidations on major exchanges like Binance, Bybit, and OKX, while no long liquidati...
Poolbeg Pharma has secured funding to complete its clinical trials through to the second quarter of 2028. The company is currently recruiting patients for its TOPICAL trial of POLB 001, a drug aimed at preventing cytokine release syndrome in cancer p...
Genflow Biosciences will present full results from its canine ageing trial at the Animal Longevity Summit in Toronto, highlighting the safety and potential health benefits of its GF-1004 treatment aimed at slowing ageing. The company is also progress...
Bitcoin's price fell below $83,000 on September 28-29, triggering the liquidation of about $500 million in leveraged crypto positions and impacting 129,197 traders. The drop was influenced by rising oil prices after geopolitical tensions and a rare 3...
Telo Genomics announced new clinical research showing its blood-based TELO-MRD test detects residual multiple myeloma cells more sensitively than traditional bone marrow tests like Adaptive clonoSEQ. The TELO-MRD liquid biopsy identifies circulating ...
